Evidence map›Paper›PMID 28761819›Full record

ReviewAdvanced pharmaceutical bulletin2017

Roghiyeh Pashaei-Asl, Khodadad Khodadadi, Fatima Pashaei-Asl, Gholamreza Haqshenas, Nasser Ahmadian, Maryam Pashaiasl, Reza Hajihosseini Baghdadabadi

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced pharmaceutical bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.Journal of chemical information and modeling · 2024
    Article
  2. Sulfoglycodendron Antivirals with Scalable Architectures and Activities.bioRxiv : the preprint server for biology · 2024
    Article
  3. Review
  4. Review
  5. Newer Methods Drive Recent Insights into Rab GTPase Biology: An Overview.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Roghiyeh Pashaei-AslDepartment of Biology, Payame Noor University, Tehran, Iran.
Khodadad KhodadadiGenetic Theme, Murdoch Children's Research Institute, Royal Children's Hospital, The University of Melbourne, Melbourne, Australia.
Fatima Pashaei-AslMolecular Biology Laboratory, Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Gholamreza HaqshenasMicrobiology Department, Biomedical Discovery Institute, Monash University, Melbourne, Australia.
Nasser AhmadianTransplantation Center, Department of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran.
Maryam PashaiaslDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza Hajihosseini BaghdadabadiDepartment of Biology, Payame Noor University, Tehran, Iran.
Payame Noor University · IRBiotechnology Research Center · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Finding novel and effective antibiotics for treatment of

Indexed as

DrrA (SidM)Intracellular replicationLegionella pneumophilaLepA and LepBRabVesicular trafficking

Identifiers

PMID28761819
PMCPMC5527231
OpenAlexW2752286448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.